MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers

Although, there is a high rate of good prognosis in early stage head and neck tumors, about half of these tumors are detected in advanced stages with poor prognosis. A combination of chemotherapy, radiotherapy, and surgery is the treatment option in head and neck cancer (HNC) patients. Although, cis...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolue Ghasaban, Faezeh, Maharati, Amirhosein, Zangouei, Amir Sadra, Zangooie, Alireza, Moghbeli, Meysam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428558/
https://www.ncbi.nlm.nih.gov/pubmed/37587481
http://dx.doi.org/10.1186/s12935-023-03010-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428558/
https://www.ncbi.nlm.nih.gov/pubmed/37587481
http://dx.doi.org/10.1186/s12935-023-03010-9

Ejemplares similares